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The association of Group A streptococci with impetigo and other superficial 
skin infections has recently been reemphasized by studies from several different 
geographical areas (1-6). The original observations of Parker, Tomlinson, and 
Williams (1) and of Barrow (2), that Group A streptococci isolated from skin 
lesions seldom give a precipitin reaction with any of the M-typing antisera in 
general use, have subsequently been confirmed by studies of impetigo in children 
(3-5).  Only 3  of 86 impetigo strains  examined by Parker and  coworkers (1) 
were typable by the precipitin method, as were only 4 of the 53 impetigo strains 
more recently reported by Markowitz et al.  (3).  Since the M  antigen is gen- 
erally believed to be an important factor in the virulence of Group A strepto- 
cocci isolated from infections other than superficial skin lesions, the failure of 
production of this antigen by impetigo strains, if confirmed, would suggest an 
important difference between the pathogenesis of streptococcal skin infections 
and other streptococcal infections (7). 
When  characterized  by T-agglutination  reactions,  most  streptococci from 
superficial skin infections give one of the three patterns, 3/13/B3264, 5/27/44, 
or  8/25/Imp.19  (1-5).  Strains  which are agglutinated  by one or more of the 
sera 3,  13, and B3264 include members of M  Types 3 and 13 as well as many 
other strains that do not give an M-precipitation reaction but are agglutinated 
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by all three sera.  It is the latter which form a large proportion of strains found 
in skin lesions. 
Characterization by T-agglutination of strains isolated from skin lesions  of 
children during a  study of pyoderma at the Cass Lake and Red Lake Indian 
reservations in Minnesota (5) gave results similar to those previously described 
(1-4). A total of 257 strains were examined; 43 % were of T pattern 3/13/B3264, 
16% were of T  pattern 8/25/Imp.19, and 16% were of T  pattern 5/27/44,  11, 
or 12. A fourth T pattern, 15/17/19/23/47, accounted for 10 % of the pyoderma 
strains  examined.  In contrast to previous experience,  a  significant proportion 
of pyoderma strains isolated in this study (14%) gave precipitin reactions with 
Type 41 antiserum; these reactions were seen only among strains of T  pattern 
3/13/B3264. Since precipitin reactions due to M protein had seldom been found 
among pyoderma streptococci and Type 41 M had not been previously reported 
among strains of this agglutination pattern, it seemed of importance to establish 
beyond doubt the nature  of the precipitating  antigen in these  strains.  When 
this antigen was indeed found to be an M  antigen, other nontypable pyoderma 
strains were studied for M  antigens. This paper will demonstrate the occurrence 
of  Type  41  M  antigen  and  of  three  apparently  new  M  antigens--Types 
Schoenborn,  Hanson,  and  Kingbird--among  Group  A  strains  isolated  from 
superficial skin infections. 
Methods 
The following strains of Group A streptococci, isolated from individual children in an 
epidemiologic study of skin infections and nephritis at the Cass Lake and Red Lake Indian 
reservations in Minnesota (5) were used in indirect bactericidal tests: 
Strains of T pattern 3/13/B3264 
Type Schoenborn  Type Hanson  Type 41 
CV 686  CV 832  CV 162 
CV 1060  CV 265  Colindale 850 
CV 830B  CV 782 
CV 685A 
Strains of T pattern 15/17/19/23/47 
Type Kingbird 
CV 581 
CV 1085 
CV 601A 
CV 872 
Two stock Type 41 strains were also used in the experimental work: strain C101/10/1, a 
Type 41 strain which gave no agglutination with available T antisera-obtained from Dr. 
Rebecca Lancefield, and strain C101/100/10, a more highly mouse-passaged variant of the 
same strain. 
Streptococci were grown in  commercial Todd-Hewitt broth  (Difco Laboratories Inc., TOP,  WANNAM.AKER, MAXTED,  AND  ANTHONY  669 
Detroit, Mich.). M antigen was extracted with N/5 hydrochloric acid and capillary precipitin 
tests were performed as described by Swift, Wilson, and Lancefield (9). M-typing antisera of 
Types  1-6, 8,  9,  11-15,  17-19,  22-34, 36-44, 46-49, and  51 were used. Antisera for Types 
27, 28, 34, 48, 49, and 51 were obtained through the kindness of Dr. Rebecca Lancefield and 
Type 9 antiserum was made in the Central Public Health Laboratory,  Colindale, London, 
England.  The remaining antisera were obtained from the Communicable Disease Center in 
Atlanta,  Ga.  Type 41  antisera  were supplied  by both  the  Communicable  Disease  Center 
(CDC Type 41 antiserum) and the Central Public Health Laboratory (CPHL Type 41 anti- 
serum). T-agglutination sera were made at the Central Public Health Laboratory, and agglu- 
tination tests were performed by the method described by Williams (8).  The serum-opacity 
reaction produced by strains was determined by a modification (11) of the method described 
by Gooder (10). 
Vaccines and antisera were made by a modification of the Lancefield technique described 
by Moody et al.  (12).  Cells were grown for 16-18  hr at 37°C in 1.6 liters of Todd-Hewitt 
broth, killed by heating at 56°C for 30 rain, washed three times in 0.9% saline, and suspended 
in 100 ml of 0.9% saline. Rabbits were immunized with 0.5-1.0 ml per injection of the vaccine, 
depending upon tolerance, in a  schedule of three daily injections followed by 4 days of rest 
before the next injection. Antiserum to be used for typing was absorbed  with heterologous 
strains (12). 
Indirect bactericidal tests were performed as described by Lancefield (13). A 10  4  dilution 
of a 2-3 hr growth was made in Todd-Hewitt broth of strains to be tested and further diluted 
1/4, 1/16, and 1/64 in Todd-Hewitt broth; 0.1 ml of each of the four dilutions was incorporated 
in a blood agar pour plate to determine the number of streptococcal chains inoculated  into 
each tube. All antisera used were heated at 56°C for 30 rain prior to use. 0.1 ml of each of 
the four dilutions of ceils, 0.05 ml of antiserum, and 0.3 ml of fresh heparinized whole human 
blood were placed in 10  X  100 ml tubes. The tubes, capped with smooth rubber stoppers, 
were rotated at 8 g at 37°C for 3 hr. At the end of this time, a 0.1 ml sample from each tube 
was incorporated into blood agar pour plates. The plates were incubated at 37°C for 18 hr 
and a  colony count was done; this  figure  is  recorded  in  the  results  listed  in subsequent 
tables of indirect bactericidal tests. The actual number of chains contained in each tube at 
the end of the tests may be determined by multiplying the recorded figure by a factor of 4.5. 
Growth of strains in normal human  blood was determined in a  similar fashion with the 
exception that antiserum was not added to the system. Data from the studies of Lancefield 
(14,  15) would indicate that strains containing more than moderate amounts of M  antigen 
grow in normal human blood so as to exceed the number of chains inoculated by a factor of 
at least 40 after 3 hr rotation at 37°C.  For the purpose of this paper, a strain was considered 
to show significant growth if the number of chains obtained after 3 hr rotation at 37°C  in- 
creased by a factor of 64 or greater beyond the number inoculated. 
In order to estimate the frequency of occurrence of Type 41 and the new provisional types 
in skin lesions among children of the two Indian reservations, strains obtained from patients' 
initial skin cultures positive for Group  A  streptococci in this study  (5)  were reexamined. 
Lyophilized cultures of all such strains with agglutination patterns  of 3/13/]33264 and  15/ 
17/19/23/47 and representative strains of other patterns were regrown and Lancefield extracts 
prepared for testing with absorbed antisera of Type 41 and the new provisional types. 
RESULTS 
Type 41 among Pyoderma Strains of T-Agglutination Pattern 3/13/B3264.-- 
Among the 257 pyoderma strains isolated in initial cultures in the Indian reser- 
vation  study,  35  (14%)  were  found  to  precipitate  with  Type  41  antiserum; 670  M  ANTIGENS  AMONG  GROUP  A  STREPTOCOCCI 
strains whose  extracts precipitated with this antiserum were  all of T  pattern 
3/13/B3264.  In order to investigate this precipitating antigen, a  vaccine pre- 
pared  from  a  3/13/B3264  pyoderma  strain  producing  the  antigen,  strain 
CV162,  was injected into rabbits. Serum (No. 694) from an immunized rabbit 
after  suitable  absorption,  gave  a  strong  precipitin  reaction  with  extracts  of 
CV162  and  of  the  stock Type 41  strain  C101/10/1,  but  failed to  react  with 
extracts of any of the laboratory stock strains of other serotypes. Extracts of all 
TABLE I 
Indirect Bactericidal Tests with Type 41 Antiserum  and Type 41 Strains 
Strain 
clol/ao/1 
Type 41 
T  pattern not  typ- 
able 
CV162 (Red Lake) 
Type 41 
T pattern 
3/13/B3264 
No. of chains inoculated 
No. of chains at end of test with normal 
human blood and 
(a)  694 antiserum 
(b)  CDC Type 41, lot 3 antiserum 
(c)  Type 6 antiserum 
No. of chains inoculated 
No. of chains at end of test with normal 
human blood and 
(a)  694 antiserum 
(b)  CDC Type 41, lot 3 antiserum 
(c)  Type 6 antiserum 
Re sults  of bactericidal tests 
with cultures diluted 
10-5  10-~  10-~  i0-~  -y-  -W"  -~ 
80  22  7  6 
8  £  0  0 
1  1  0  0 
1500  43£  90  0 
204  48  22  9 
106  45  8  2 
94  32  5  0 
180C  ~00  364 
oo  indicates innumerable colonies with complete hemolysis of blood of the pour plate. 
4000 indicates innumerable colonies with some areas of unhemolyzed  blood. Plates contain- 
ing 500 to 4000 colonies were estimated by counting  one quarter of the plate and multiply- 
ing by four. In plates with less than 500 colonies the entire plate was counted. 
the 3/13/B3264  pyoderma strains which  had  been found  to react with  CDC 
Type 41  antiserum were found to react with No.  694  serum.  Extracts of the 
3/13/B3264  pyoderma strains which had not precipitated with CDC Type 41 
antiserum did not react with No. 694 serum. 
Gel diffusion tests were employed to compare the nature of the reaction seen 
with these antisera and extracts. CPHL Type 41 antiserum and serum No. 694 
gave single lines of identity with extracts of CV162  and  of C101/10/1.  CDC 
Type 41 antiserum also gave a line of identity with these extracts, but with the 
more highly passaged strain C101/100/10  a  second line  appeared. Absorption 
of CDC Type 41 antiserum with CV162 cells removed the major precipitin line 
but not  the  second line. Thus  the major line seen with  all sera and  extracts 
appeared to be identical. The antigen was shown to be trypsin-sensitive. TOP~ WANNAMAKER~ MAXTED, AND  ANTHONY  671 
Indirect bactericidal  tests were performed  in  the University of Minnesota 
laboratory on the two sera, CDC Type 41 and No. 694. The test streptococci 
included strains C101/10/1, CV162, and several other 3/13/B3264 pyoderma 
strains which had given a precipitin reaction with Type 41 antisera. Tests were 
made at the Central Public Health Laboratory (Colindale) on the sera CPHL 
Type 41, CDC Type 41, and No. 694. Results were similar in the two labora- 
tories and representative findings with strains CV162 and C101/10/1  are shown 
in Table I. 
In bactericidal  systems containing either Type 41 or No. 694 antiserum, the 
stock Type 41 strain C101/10/1  was almost completely killed. These two anti- 
sera also caused marked reduction in the numbers of strain CV162 and of other 
3/13/B3264 pyoderma strains which had given a precipitin  reaction with Type 
41 antisera, but never gave complete killing of any of them. In all these tests, 
serum No. 694 behaved exactly as CDC Type41 and CPHL Type 41 antiserum 
Absorption  of the two stock Type 41 sera with extracts of strain CV162 and 
other similar 3/13/B3264 pyoderma strains removed the bactericidal  activity 
from both. Our results then indicate that the pyoderma strains which had given 
a precipitin reaction with Type 41 antisera did, in fact, contain M protein of 
Type 41. 
Strains of T-agglutination pattern 3/13/B3264  accounted for 111 of the 257 
strains  (43 %)  isolated  from the initial skin cultures  obtained at the Indian 
reservation study (5). 35 of these 3/13/B3264 strains (32 %) were found to be 
Type 41  strains.  There was little nephritis seen in this study (5), and none 
could be attributed to Type 41 strains.  Type 41 strains with T pattern 3/13/ 
B3264 have also been isolated in skin cultures  and throat cultures of several 
patients and from the blood  of three patients with septicemia  in the Min- 
neapolis-St. Paul area. 
At Colindale, 36 cultures from various parts of Britain, all with the T-ag- 
glutination pattern 3/13/B3264,  were examined but only one gave a precipitin 
reaction with Type 41 serum. However, among 6 strains with T pattern 3/13/ 
B3264, isolated from skin lesions and burns in Canada and sent to Colindale, 
five were found to be Type 41. 
Reports that Type 41 streptococci were prevalent in Trinidad (6) prompted 
a reexamination  of a large collection of skin strains isolated there.  In all, 365 
cultures with the T-agglutination pattern 3/13/B3264  were tested with Type 
41 serum at Colindale, but none of them gave a precipitin reaction with Type 
41 serum. 
Type  Schoenborn (Type  52)  among Pyoderma Strains of  T-Agglutination 
Pattern 3/13/B3264.--Despite  the prevalence of pyodema strains agglutinating 
as T 3/13/B3264 in the studies on the Indian reservation,  only 32 % were found 
to be Type 41  strains; the remainder (76 strains)  were not typable with the 
available M-typing antisera.  Nearly all strains of this T-agglutination pattern, 672  M  ANTIGENS  AMONG  GROUP  A  STREPTOCOCCI 
regardless of whether they reacted with Type 41 antiserum, were serum-opacity 
negative, a finding which in other studies correlated with the presence of an M 
antigen (10,  16). Two of these strains,  CV686 and CV1060,  were tested in an 
indirect bactericidal test in the presence of normal human blood with the addi- 
tion of Type 6 and Type 41 antisera. The number of chains obtained after 3 hr 
incubation in the presence of either antiserum exceeded the number inoculated 
by a factor of 80-100. This finding suggested the possibility of an M  antigen in 
these strains which was different from the Type 41 antigen. 
TABLE II 
Indirect Bactericidal Tests with Type Schoenborn Antiserum and 
Type ~choenborn Strains 
Strain 
CV686 
Type Schoenborn 
T pattern 
3/13/B3264 
CV1060 
Type Schoenborn 
T pattern 
3/13/B3264 
6365 (Trinidad) 
Type Schoenboru 
T pattern 
3/13/B3264 
No. of chains inoculated 
No. of chains at end of test 
(a)  with  Type Schoenborn  antiserum 
(b)  with Type Hanson antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Schoenborn  antiserum 
(b) with Type Kingbird antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Schoenborn  antiserum 
(b)  with Type 41 antiserum 
(c) with Type 3 antiserum 
Results of bactericidal tests 
with cultures diluted 
10-6 
157 
3 
~o 
204 
9 
3100 
239 
58 
~o 
10-5 
4 
42 
1 
47 
1 
1400 
43 
0 
3000 
4OO0 
10-5 
16 
16 
2 
720 
11 
0 
255 
22 
0 
1100 
1600 
10-6 
64' 
4 
0 
230 
2 
0 
39 
8 
0 
211 
38O 
See legend under Table I for details of test. 
Rabbits were immunized with a vaccine prepared from strain CV686 (isolated 
from  patient  Schoenborn).  The antisera  obtained produced  strong precipitin 
reactions with CV686 extracts but only weak reactions with extracts of heter- 
ologous strains.  After suitable  absorption,  the  antiserum was tested  with  ex- 
tracts of all established Group A streptococcal types and also with extracts of 
several pyoderma strains with agglutination patterns other than 3/13/B3264; 
no precipitation was obtained with any of these extracts. The absorbed antisera 
did,  however, give a  strong reaction with  CV686 extract.  Lancefield extracts 
prepared from all  111  initial  skin isolates of T  pattern  3/13/B3264 from the 
Indian reservation study were tested with absorbed CV686 antiserum. Moderate 
to strong precipitation was found with extracts of 40 of these strains. Strains of TOP,  WANNAMAKER,  MAXTED~ AND  ANTHONY  673 
T  pattern  3/13/B3264 previously classified  as Type 41  strains  did not react 
with this antiserum. 
Indirect bactericidal tests with Type Schoenborn antiserum were performed 
with  several  strains  which  had  shown precipitation  with  this  antiserum;  the 
results are shown in Table II. Strains CV686,  CV1060,  and 6365 were almost 
completely killed in indirect bactericidal tests with Type Schoenborn antiserum; 
TABLE III 
Indirect Bactericidal  Tes#s with Type Schoenborn Antiserum and Heterologous Strains 
Strain 
CV 265 
Type Hanson 
T pattern 
3/13/B3264 
CV1085 
Type Kingbird 
T pattern 
15/17/19/23/47 
CV162 
Type 41 
T pattern 
3/13/B3264 
AN1271 
Type 3 
T pattern 
3/13/B3264 
No. of chains inoculated 
No. of chains at end of test 
(a)  with  Type Schoenbom  antiserum 
(b)  with Type Hanson antiserum 
No. of  chains  inoculated 
No. of  chains  at end of test 
(a) with  Type Schoenbom antiserum 
(b) with Type Kingbird antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Schoenborn  antiserum 
(b)  with Type 41 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Schoenbom  antiserum 
(b)  with Type 3 antiserum 
Results of bactericidal tests 
with cultures diluted 
10_  6  10  -5  lO-i 
365  84  31  4 
~o  2000  750  113 
129  0  4  0 
215  70  22  2 
1300  384  120 
0  0  0  0 
228  65  25]  4 
~o  1700  600  156 
2  0  0 
407  124  46  9 
4000  1200  270 
1  2  0  0 
See legend under Table I for details of test. 
a  fourth strain,  CV830,  not shown in  Table  II, was similarly killed.  Strains 
which were typable with Type Schoenborn antiserum showed no inhibition of 
growth in  the presence of Type 3  antiserum,  Type 41  antiserum,  or antisera 
from two other provisional types subsequently identified  (Type  Hanson  and 
Type Kingbird).  Furthermore,  Type Schoenborn antiserum exhibited  specific 
bactericidal activity in that it did not inhibit the growth of a Type 3, Type 41, 
Type Hanson, or Type Kingbird strain, as shown in Table III. The behavior of 
Type Schoenborn antiserum in indirect bactericidal tests clearly indicates that 
it  contains antibodies  to the M  antigens  of strains  giving precipitation  with 674  M ANTIGENS AMONG GROUP A STREPTOCOCCI 
this antiserum. Type Schoenborn has met the requirements of the International 
Committee of Bacterial Nomenclature for designation as Type 52. 
Type Schoenborn strains accounted for 40 of the 257 Group A strains (16%) 
isolated from skin lesions in the Indian reservation study of pyoderma. This 
type  has  also  been  sporadically  isolated  from pyoderma lesions and  throat 
cultures in the Minneapolis-St. Paul area. Additionally, an impetigo strain of 
T  pattern 3/13/B3264 isolated in the United Kingdom in 1956 has been identi- 
fied as Type Schoenborn by precipitin test. 
Type Schoenhorn strains have also been identified among streptococci ob- 
tained in an epidemic of skin infections and nephritis in Trinidad. Dr. Elizabeth 
Potter kindly sent us four strains  isolated in Trinidad which were originally 
thought to be Type 41 strains on the basis  of precipitation reactions (6). No 
appreciable growth inhibition of these strains could, however, be demonstrated 
in indirect bactericidal tests with Type 41 antiserum.  1 When examined in our 
laboratories,  all  four  strains  had  a  T-agglutination  pattern  of  3/13/B3264. 
Their extracts were found to give weak to moderate precipitation with CDC 
Type 41 antiserum, no reaction with CPHL Type 41 antiserum, but strong pre- 
cipitation  with  Type  Schoenborn antiserum.  In  a  gel  diffusion system,  one 
Trinidad strain, 6365, was tested and was shown to be different from Type 41 
strain and similar to strain CV 1060, a Type Schoenborn strain isolated at the 
Red Lake reservation. Indirect bactericidal tests performed with strain 6365 
and  Type 3,  Type 41,  and  Type Schoenborn antisera  demonstrated  specific 
killing with Type Schoenborn antiserum but no killing with Type 3 or Type 41 
antisera (Table II). Other strains isolated from Trinidad have been found by 
the Colindale laboratory to give precipitation with Type Schoenborn antiserum 
and to be killed in indirect bactericidal tests with Type Schoenborn antiserum. 
Preliminary observations thus  suggest  that  Type Schoenborn strains  have a 
more than local distribution. 
Type Hanson (Proposed Type 53) among Pyoderma  Strains of T-Agglutination 
Pattern 3/13/B3264.--Despite  the identification of Type 41 and Type Schoen- 
born  M  antigens  among  skin  isolates  of T  pattern  3/13/B3264,  approxi- 
mately one-third of the strains of this T  pattern isolated in the  Indian reserva- 
tion study remained nontypable. The majority of these strains failed to produce 
a  serum-opacity reaction. One such nontypable strain,  CV 832  (isolated from 
patient Hanson),  was found to grow well in  rotated human blood.  Sera  ob- 
tained from rabbits immunized with a  vaccine prepared from strain CV 832, 
after suitable absorption with heterologous strains, gave no precipitin reaction 
with  extracts of all  established  types of Group A  streptococci, but  did give 
moderate precipitation with an extract of strain  CV 832. The absorbed anti- 
serum was tested with extracts of the initial skin isolates of T  pattern 3/13/ 
B3264  from the  Indian  reservation study;  no  precipitation  was  found  with 
1 Potter, E. V. Personal communication. TOP~ WANNAMAg~W~  MAXTED~ AND ANTHONY  675 
extracts of strains in this T  pattern previously classified as Type 41  or Type 
Schoenborn, but moderate reactions were found with extracts of 22 of the 36 
previously nontypable strains. 
In indirect bactericidal tests (Table IV), the growth of all four Type Hanson 
strains  examined  was  inhibited  by  Type  Hanson  antiserum.  Type  Hanson 
strains  showed no inhibition  of growth  in  the presence of Type 3,  Type 41, 
TABLE IV 
Indirect Bactericidal Tests ~4~k Type Hanson Antiserum and Type Hanson Strains 
Strain 
CV832 
Type Hanson 
T pattern 
3/13/B3264 
CV685A 
Type Hanson 
T pattern 
3/13/B3264 
CV265 
Type Hanson 
T pattern 
3/13/B3264 
CV832 
Type Hanson 
T pattern 
3/13/B3264 
No. of chains inoculated 
No. of chains at end of test 
(a) with TypeHanson antiserum 
(b) with Type 41 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Hanson antiserum 
(b) with Type 3 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a) with Type Hanson antiserum 
(b) with Type Schoenbom antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a) with Type Hanson antiserum 
(b) with Type Kingbird antiserum 
Results of bactericidal tests 
with cultures diluted 
10-5  10-5  10-1 
10-1  4  16  64 
220  56  17  2 
146  5  7  0 
1600  620  435 
187  57  12  1 
357  123  7  1 
4000  750  135 
356  84  31  4 
129  0  4  0 
2000  750  113 
257  50  9  2 
161  23  1  0 
2500  570  0 
See legend under Table I for details of test. 
Type Schoenborn, or Type Kingbird antisera. The bactericidal activity of the 
antiserum was directed only against strains which  also precipitated with this 
antiserum; Type Hanson antiserum did not inhibit the growth of the Type 3, 
Type 41,  Type Schoenborn,  or Type Kingbird  strains  examined  (Table  V). 
Type Hanson thus appears to represent a new provisional type, and should be 
referred to as proposed Type 53,  pending  official confirmation by the  Inter- 
national Committee of Bacterial Nomenclature. This type accounted for 22 of 
the 257  (9%)  Group A  streptococcal skin isolates obtained in the Cass Lake 
and Red Lake study. 
Type Kingbird (Proposed Type 54) among Pyoderma Slrains of T-Agglutina- 676  ~i  ANTIGENS  A~IONG  GROUP  A  STREPTOCOCCI 
tion  Pattern  15~17/19~23~47.--Approximately  10 %  of the  skin isolates from 
children  at  the  Indian  reservations  were  found  to  have  a  T-agglutination 
pattern of 15/17/19/23/47,  a pattern which had not previously been described 
among pyoderma strains  (5).  These strains were not typable with any of the 
M-typing antisera  available, including the antisera of types within that T-ag- 
glutination pattern,  namely, Types 15,  17,  19,  23, 30, and 47. The pyoderma 
TABLE V 
Indirect Bactericidal Tests with Type Hanson Antiserum and Heterologous Strains 
Strain 
CV1060 
Type Schoenborn 
T pattern 
3/13/B3264 
CV581 
Type Kingbird 
T pattern 
15/17/19/23/47 
"Richards" 
Type 3 
T pattern 
3/13/B3264 
CV162 
Type 41 
T pattern 
3/13/B3264 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Hanson antiserum 
(b)  with Type Schoenborn antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Hanson antiserum 
(b)  with Type Kingbird antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Hanson antiserum 
(b)  with Type 3 antiserum 
No.  of chains inoculated 
No. of chains at end of test 
(a)  with Type Hanson antiserum 
(b)  with Type 41 antiserum 
Results of bactericidal tests 
with cultures diluted 
10-~ 
204 
4O00 
9 
154 
ao 
ot 
I 
16o[ 
o~ 
13 
383 
oo 
272 
10-5_  10-5 
4  16  __ 
47  11 
400  328j 
48 
:200  125 
0  0 
40  11 
~ 0  320~ 
118~o  252070 
39  11 
10-5 
2 
60 
0 
3 
122 
0 
3 
404 
0 
8 
188 
0 
See legend under Table I for details of test. 
strains  of this  pattern  were uniformly negative for the  serum-opacity factor. 
One  such  strain  examined,  strain  CV  581  (isolated  from patient  Kingbird), 
grew well in rotated normal human blood. Antisera obtained from rabbits im- 
munized with a vaccine of strain CV 581, when suitably absorbed, were found 
to  be  specific  in  that  they  did  not  cause  precipitation  with  extracts  of  all 
established types of Group A  streptococci or extracts of nontypable pyoderma 
strains of heterologous serotype, but gave strong precipitation with an extract 
of strain CV 581. Extracts prepared from all 26 initial skin isolates of T  pattern 
15/17/19/23/47  from  the  Indian  reservation  gave  strong  precipitation  with 
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Indirect bactericidal tests performed on several Type Kingbird strains with 
Type Kingbird antiserum are shown for strain CV 581 in Tables V and VI, and 
for strain  CV  1085  in Table III. Type Kingbird  antiserum  was found to kill 
completely strain  CV 581  and  strain  CV  1085  in  the  tests;  almost complete 
TABLE VI 
Indirect Bactericidal Tests with Type Kingbird Antiserum and Type Kingbird Strains 
Strain 
CVS81 
Type Kingbird 
1" pattern 
15/17/19/23/47 
CV581 
I~£pe Kingbird 
T pattern 
15/17/19 23/47 
CV581 
Type Kingbird 
T pattern 
15/17/19/23/47 
CV581 
Type Kingbird 
T pattern 
15/17/19/23/47 
Results of bactericidal tests 
with cultures diluted 
~_  10  -5  10-~ 
10-"  -  ~  54 
No. of chains inoculated  173  39  8  4 
No. of chains at end of test 
(a) with Type Kingbird antiserum  0  0  0  0 
(b)  with Type 41 antiserum  2700  910  300  0 
No. of chains inoculated  148  35  19  5 
No. of chains at end of test 
(a)  with Type Kingbird antiserum  2  1  0  0 
(b)  with Type 15 antiserum  ~  700  197  55 
(c)  with Type 17 antiserum  3000  800  408  147 
No. of chains inoculated  100  31  7  4 
No. of chains at end of test 
(a)  with Type Kingbird antiserum  42  0  0  0 
(b)  with Type 19 antiserum  oo  1500  237  103 
(c)  with Type 23 antiserum  oo  1500  272  0 
No. of chains inoculated  103  25  7  1 
No. of chains at end of test 
(a)  with Type Kingbird antiserum  0  0  0  0 
(b)  with Type 30 antiserum  oo  1000  486  0 
(c)  with Type 47 antiserum  o0  1700  116  74 
Results  of indirect  bactericidal  tests with Type Kingbird  strains  and Type Schoenbom 
antiserum  are shown in Table III and results with Type Hanson antiserum  in Table V. 
See legend under Table I for details of test. 
killing was also obtained with two other Type Kingbird strains,  CV 601A and 
CV  872,  which  are  not  shown  in  the  tables.  The  growth  of Type  Kingbird 
strains was not inhibited  in indirect bactericidal tests by antisera for Types 15, 
17, 19, 23, 30, 41, 47 (Table VI), Schoenborn (Table III), or Hanson (Table V). 
Unabsorbed Type Kingbird antiserum did not inhibit the growth of the Types 
15, 17, 19, 23, 30, 41, 47 (Table VII), Schoenborn (Table II), or Hanson (Table 
IV)  strains  tested  in indirect  bactericidal  tests.  Our evidence,  then,  suggests 
that Type Kingbird represents a new provisional type, which should be referred 678  M  ANTIGENS  AMONG GROUP  A  STREPTOCOCCI 
to  as  proposed  Type 54,  pending  official confirmation  by the  International 
Committee of Bacterial Nomenclature. 
26 of the 257  initial skin isolates  (10%)  from the Indian reservation study 
were Type Kingbird strains. 
TABLE  VII 
Indirect Bactericidal Tests with Type Kingbird Antiserum and Helerologous Strains 
S~a~ 
CV162 
Type 41 
T  pattern 
3/13/B3264 
T15/32 
Type 15 
T  pattern 
15/17/19/23/47 
I17E/135 
Type 17 
T  pattern 
15/17/19/23/47 
J17D 
Type 19 
T  pattern 
15/17/19/23/47 
5802 
Type 23 
T  pattern 
15/17/19/23/47 
Colindale No. 8195 
Type 30 
T  pattern 
15/17/19/23/47 
C744 
Type 47 
T  pattern 
15/17/19/23/47 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 41 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 15 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 17 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 19 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 23 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 30 antiserum 
No. of chains inoculated 
No. of chains at end of test 
(a)  with Type Kingbird antiserum 
(b)  with Type 47 antiserum 
Results of bactericidal tests 
with cultures diluted 
lO-i  lO-i  lO-S 
10-5 
4  16  64 
383  118  27  8 
~  2300  630 
272  39  11  0 
229  59  18  8 
3000  373  242 
19  15  2  1 
426  111  47  12 
3300  1100  230 
37  5  0  3 
162  47  6  1 
1500  387  139 
10  3  0  1 
144  52  8  3 
~  600  442 
0  0  0  0 
135  38  6  5 
3700  570  0 
2  0  0  0 
432  123  45  7 
~  1260  294 
0  0  0  0 
Results of indirect bactericidal tests of a  Type  Schoenborn strain with Type  Kingbird 
antiserum are shown in Table II, and of a  Type Hanson strain with Type Kingbird anti- 
serum in Table IV. 
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M-Typing  of Pyoderma Strains Isolated in the Indian  Reservation Study.-- 
Classification  of strains isolated from the first skin cultures containing Group A 
streptococci obtained from children with pyoderma at the two Indian reserva- 
tions  is shown in Table VIII.  Prior to the identification  of Type 41  strains 
among  the 3/13/B3264 isolates and prior to the identification of provisional 
Types Schoenbom, Hanson, and Kingbird,  only 9 of these 257 strains (3.5 %) 
TABLE VIII 
Cass Lake and Red Lake Reservation Study of Skin Infections 
Classification of strains isolated from initial skin cultures positive for Group A streptococci. 
]  [ 
T pattern  M type  [ No. of strains  [  %strains°f  total 
I 
M-typable strains 
3/13/B3264 
15/17/19/23/47 
12 
Not identified 
41 
Schoenborn 
Hanson 
Kingbird 
12 
31 
35 
40 
22 
26 
2 
7 
13.7 
15.6 
8.6 
10.1 
0.8 
2.7 
Total M-typable  .........................................  132  51.4 
Non-M-typable strains 
3/13/B3264 
8/25/Imp.  19 
5127144 
28 
11 
12 
4 
14 
Not identified 
14 
40 
20 
19 
12 
6 
3 
1 
10 
5.4 
15.6 
7.8 
7.4 
4.7 
2.3 
1.2 
0.4 
3.9 
Total non-M-typable  ......................................  125  48.6 
were M-typable.  Currently,  132 of the  257 strains  (51%)  are  typable by the 
precipitin method with the use of the antisera for Type 41  and the  new pro- 
visional types. During the same period of time as the Indian reservation study, 
62 of 140 strains (44 %) of Group A streptococci isolated from throat cultures of 
children with pharyngitis in St. Paul-Minnesota were typable by the precipitin 
methodJ With the use of available antisera, including those of the new types, 
the proportion of streptococci from skin lesions  which have an identifiable M 
antigen appears to be similar to that found with strains isolated in association 
with pharyngitis in Minnesota. 
2 Top, F. H., Jr., E. L. Kaplan, and L. W. Wannamaker. Unpublished observations. TABLE IX 
Growth in Rotated Normal Human Blood of Skin Strains of Group A Streptococci which 
Failed to React with M Antisera 
Strain 
~V753 Type N.T.* 
F agglutination 
5/27/44 
2V822B Type N.T. 
r  agglutination 
5/27/44 
2V963 Type N.T. 
F agglutination 
8/25/Imp. 19 
2V264 Type N.T. 
r  agglutination 
8/25/Imp. 19 
2V5 Type N.T. 
F agglutination 28 
2V370 Type N.T. 
F agglutination 4 
2V656 Type N.T. 
F agglutination 11 
RLl128 Type N.T. 
F agglutination 12 
~43/137/10 Type 6 
F agglutination 6 
~43 glossy Type N.T, 
F agglutination 6 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chins inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
No. of chains inoculated 
No. of chains at end of test in normal 
human blood 
Results of tests with 
cultures diluted 
10-~  10  ~  10  -6  10-6 
4  16  64 
48  14  4  1 
oo  2000  600  126 
105  31  7  2 
4000  308  100 
115  40  9  2 
1300  252  168 
217  47  18  4 
~  800  141 
78  17  9  2 
3600  1700  346  0 
106  48  8  2 
3800  1200  184  78 
98  25  8  3 
2200  960  161  21 
105  15  3  1 
1100  660  275  13 
362  80  23  12 
~  2000  660 
380  88  31  13 
14  3  0  0 
The figures in the columns showing the number of chains at end of test in normal human 
blood represent the number of chains obtained in a 0.1 ml sample from each tube. The actual 
number of chains in each tube at the end of the test can be obtained by multiplying this 
figure shown in the table by a factor of 4. 
* N.T., nontypable. 
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Growth in Human  Blood of Representative Pyoderma Streptococci.--Because 
49 % of Group A streptococci isolated from skin lesions in the Indian reservation 
study are at present nontypable by the precipitin method, it was of interest to 
explore the possibility that these remaining nontypable strains might contain an 
unrecognized M  antigen. Therefore, randomly selected strains of each T-ag- 
glutination pattern  isolated  at  the  reservations  were  tested  for  growth  in 
heparinized whole human blood, rotated for 3 hr at 37 ° C. Two control strains-- 
$43/137/10,  a  Type 6  strain whose extracts gave strong precipitation  with 
Type 6 antiserum, and $43 glossy, a nontypable variant of the same strain-- 
were tested similarly for purposes of comparison. The results of these tests are 
shown in Table IX. Growth in human blood is evident with all 8 of the non- 
typable pyoderma strains tested. With the possible exception of strain RL 1128, 
the number of chains found in each tube at the end of the test (the number of 
chains in a  0.1  ml sample multiplied by a  factor of 4)  exceeded the number 
inoculated by a factor of greater than 64. Their growth was indeed comparable 
to the  growth of the known M-typable strain $43/137/10.  In  contrast,  the 
non-M-typable strain $43  glossy was  killed under  identical  test  conditions. 
These findings are compatible with the possibility that the  pyoderma strains 
tested, although nontypable in precipitin tests with currently  available anti- 
sera, do contain an unidentified M  antigen. 
DISCUSSION 
Attention was drawn in an earlier report from Colindale  (1)  to the infre- 
quency with which Group A streptococci from skin lesions could be typed by the 
M-precipitin method. This was not taken as evidence that these organisms were 
necessarily M-negative, but simply that they did not appear  to form the M 
antigens commonly present in strains with the same T-agglutination pattern 
which had been isolated from infections other  than  pyoderma in  the  same 
locality. In England and Wales, for example, over half of the cultures aggluti- 
nated by one or more of the sera 3,  13, and B3264  gave a precipitin reaction 
with 3M antiserum, but the proportion of 3M-positive cultures among members 
of the 3/13/B3264 T  pattern was 90% for scarlet fever, 59% for acute phar- 
yngitis and  14%  for impetigo  (17).  The remaining 3/13/B3264  strains from 
impetigo lesions could not be typed with available M  antisera. 
The results of the present investigation show that a large proportion (87 %) 
of Group A streptococci with the T pattern 3/13/B3264 isolated from the skin 
lesions  of children from two  Indian reservations  in Minnesota produced M 
antigens of Type 41, Type Schoenborn, or Type Hanson. All pyoderma strains 
of a second T pattern 15/17/19/23/47,  were found to elaborate still a fourth M 
antigen, Type Kingbird. With the use of Type 41 antiserum and the antisera of 
the new provisional types, half of the pyoderma strains isolated in the Indian 
reservation study were found to produce an M  antigen. In a different locality, 582  M  ANTIGENS AMONG  GROUP  A  STREPTOCOCCI 
the Minneapolis-St. Paul area, nearly 40 % (18 of 48) of pyoderma strains were 
M-typable by the use of the same antisera. That other pyoderma strains which 
are currently nontypable with available  M-typing antisera may contain uni- 
dentified M antigens is suggested by the excellent growth in human blood of all 
but one of the eight strains tested. Our findings indicate that Group A strepto- 
cocci isolated from superficial skin infections commonly produce an M antigen. 
It seems probable  that the delay in recognition of these M  antigens  among 
pyoderma streptococci  is principally a reflection that pyoderma strains have 
not been systematically examined for new M  antigens.  With the notable ex- 
ception of Type 49 (the original Red Lake strain), it would appear  that at the 
time most of the studies defining the established types were performed,  atten- 
tion was centered  predominantly on strains commonly associated  with phar- 
yngitis, scarlet fever, or acute rheumatic fever. If, as has been suggested by the 
English workers (1, 2, 17), superficial skin infections are associated with distinct 
streptococcal  serotypes  not commonly encountered  in other streptococcal  in- 
fections,  it is not surprising  that these  new  types isolated  from skin lesions 
were not identified among strains isolated from sources other than skin. Nor is 
it surprising that these and other skin strains have been classified as nontypable 
when tested against a battery of M-typing antisera developed from strains ob- 
tained predominantly from non-skin sources. 
In view of the previous reports  of the greater frequency of isolation of non- 
M-typable 3/13/B3254  strains from skin lesions than from pharyngitis, it is 
tempting to speculate  that the newly described M  types in this T  pattern-- 
Types 41, Schoenborn, and Hanson--may be more commonly associated with 
skin infections.  In limited studies  on strains isolated  in the Minneapolis-St. 
Paul area, both Type 41 and Type Schoenborn were indeed isolated more fre- 
quently from skin lesions than from pharyngitis. More extensive screening of 
strains from various sources with Type 41 antiserum and with the antisera of 
the new provisional  types is needed in order  to determine whether strains of 
these types are more commonly associated with skin infections and thus can be 
truly considered to be impetigo streptococcL 
The recognition of the M  antigens  among pyoderma strains was facilitated 
by the use  of three separate  microbiologic tools which may prove useful  in 
defining further M  types. These  include the T-agglutination method of clas- 
sifying Group A streptococci,  a screening test of strains for the serum-opacity 
reaction, and a test for the growth of selected strains in rotated whole human 
blood. The first method, T-agglutination, allowed classification of 94 % of all 
Group A  streptococci  isolated  in  the Indian reservation  study. Selection  of 
strains for vaccines and for subsequent testing with the M  antisera produced 
was accomplished more rationally with the use of this system than would have 
been possible had we been presented with a large number of unidentified non- 
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A  second procedure found useful in our studies is a  screening  test for the 
serum-opacity reaction. Gooder (10) and KShler (16) determined that types of 
Group A streptococci for which the production of suitable M-typing sera was 
relatively easily accomplished  generally failed to produce the  serum-opacity 
reaction. Conversely, types for which the production of typing sera was difficult, 
as well as the majority of non-M-typable strains, were found to produce the 
serum-opacity reaction. Recent work in the Minnesota laboratory on the serum- 
opacity reaction  has  confirmed  these  findings  (11).  Since  nearly  all  of  the 
3/13/B3264 isolates and  all  of the  15/17/19/23/47 isolates from the Indian 
reservation study failed to produce the serum-opacity reaction, we hypothesized 
that these strains should have a demonstrable M  antigen. Our success in pro- 
ducing M-typing antisera for Types  Schoenborn,  Hanson,  and Kingbird  (all 
strains of these types examined have failed to produce a serum-opacity reaction) 
provides further confirmation of Gooder's and K6hler's findings of the curious, 
generally inverse,  relationship of these two streptococcal antigens. 
The third procedure utilized in this study had previously been used in defining 
M  types (13,  14). Selected strains in the two T-agglutination patterns which 
failed to produce a  serum-opacity reaction  were tested for growth in whole 
human blood which was rotated to insure contact between the organisms  and 
the leukocytes. Resistance to phagocytosis of Group A streptococci in rotated 
human blood has been demonstrated to be dependent on the presence of an M 
antigen  on the organisms  (13-15,  18).  Failure of a  strain  to grow in rotated 
human blood is subject to several interpretations,  including  the absence of M 
protein on the strain or the presence of type-specific antibody in the blood used 
for  testing.  Failure  to grow in  normal  human  blood, especially if only one 
volunteer is tested, does not necessarily mean that the strain is M-negative. On 
the other hand,  growth of a  Group A streptococcus in rotated human blood 
without  type-specific antibody  is  characteristic  of M-producing  strains.  In 
this study, the excellent  growth of the strains tested suggested that they pro- 
duced an M antigen despite their lack of precipitin reactions with available M- 
typing antisera. The combined use of the T-agglutination  system, a screening 
test for the serum-opacity reaction, and a test of the growth of selected strains 
in rotated human blood thus permitted a rational investigation of M  antigens 
on these previously nontypable pyoderma strains.  It seems likely that  these 
three methods may be useful in further  investigation  of the M  antigens  of 
currently unidentified strains. 
The identification  of Type 41  and the provisional types among pyoderma 
streptococci should facilitate future investigations of superficial  skin infections 
and their sequelae.  The relative ease of identification of the new M  antigens 
suggests that further investigation of strains in the other common pyoderma T 
patterns may be fruitful. It is now possible to identify precisely a significant 
proportion of pyoderma strains by the most specific typing method available, 684  ]~[ ANTIGENS  AMONG  GROUP  A  STREPTOCOCCI 
the M-precipitin method. The new typing antisera should afford the same pre- 
cision of typing in studies of streptococcal skin infections as has been accom- 
pushed  in  studies  of  other  streptococcal  diseases.  Further  insight  into  the 
immune response of patients with streptococcal pyoderma should also be attain- 
able by determining human type-specific antibodies to the M  antigens  which 
have been newly identified. 
With respect to M  proteins it would seem that pyoderma strains must be 
considered as having the same potential virulence as strains causing other kinds 
of streptococcal infection. The recent isolation in our laboratory of Type 41 
strains from the blood of three patients with septicemia and skin infections is 
evidence in support of the virulence of pyoderma strains. Extended investiga- 
tion with the new typing antisera and that of Type 41 is indicated to establish 
more fully the role of these strains in streptococcal infections and their sequelae. 
SUMMARY 
Three new provisional types of Group A  streptococci have been identified 
among  strains  isolated from skin  infections of American Indian  Children.  A 
previously established type, Type 41, was also recognized among the pyoderma 
strains. 
Most  of  the  skin  streptococci  with  T-agglutination  pattern  3/13/B3264 
could be identified as Type 41 or as one of two new provisional types,  Schoen- 
born (Type 52) and Hanson (proposed Type 53). Strains of the third new pro- 
visional type, Kingbird (proposed Type 54), agglutinated as  15/17/19/23/47, 
a T  pattern not associated with skin infections in studies of other populations. 
Approximately half of the pyoderma strains examined were found to produce 
an M  antigen;  the proportion of M-typable strains from skin infections was 
found to be similar to that currently found in throat cultures of children with 
pharyngitis. The demonstration of M  antigens in streptococci from skin lesions 
provides evidence of their potential virulence and should facilitate their classi- 
fication in subsequent epidemiological studies. 
The authors are pleased to acknowledge the competent assistance of Miss Cherry Fraser 
and Mrs. Joyce Tigner. 
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